Jim Simons
YARW

Jim Simons’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Jim Simons’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3K Buy
+346
New +$10.1K ﹤0.01% 3197
2025
Q3 		– Sell
-211
Closed -$17.4K – 3986
2025
Q2 		$17.4K Sell
211
-2,092
-91% -$136K ﹤0.01% 3476
2025
Q1 		$182K Buy
2,303
+1,804
+362% +$222K ﹤0.01% 3093
2024
Q4 		$83.6K Sell
499
-1,234
-71% -$161K ﹤0.01% 3314
2024
Q3 		$163K Buy
1,733
+471
+37% +$44.6K ﹤0.01% 3166
2024
Q2 		$124K Sell
1,262
-350
-22% -$43.6K ﹤0.01% 3144
2024
Q1 		$247K Buy
1,612
+684
+74% +$73.7K ﹤0.01% 3157
2023
Q4 		$108K Buy
928
+408
+78% +$63.6K ﹤0.01% 3289
2023
Q3 		$105K Sell
520
-202
-28% -$44.1K ﹤0.01% 3231
2023
Q2 		$148K Buy
722
+210
+41% +$55.9K ﹤0.01% 3364
2023
Q1 		$79K Sell
512
-451
-47% -$81K ﹤0.01% 3558
2022
Q4 		$130K Sell
963
-69
-7% -$13.8K ﹤0.01% 3552
2022
Q3 		$207K Sell
1,032
-12
-1% -$3.84K ﹤0.01% 3370
2022
Q2 		$365K Sell
1,044
-28
-3% -$11.7K ﹤0.01% 3342
2022
Q1 		$627K Buy
1,072
+67
+7% +$39.8K ﹤0.01% 3037
2021
Q4 		$923K Sell
1,005
-378
-27% -$406K ﹤0.01% 2709
2021
Q3 		$1.73M Buy
1,383
+1,038
+301% +$2.01M ﹤0.01% 2202
2021
Q2 		$1.09M Buy
+345
New +$1.37M ﹤0.01% 2630
2021
Q1 		– Sell
-127
Closed -$725K – 3753
2020
Q4 		$725K Buy
+127
New +$798K ﹤0.01% 2659
2020
Q3 		– Sell
-86
Closed -$535K – 3727
2020
Q2 		$535K Buy
+86
New +$582K ﹤0.01% 2852
2020
Q1 		– Sell
-42
Closed -$704K – 3845
2019
Q4 		$704K Buy
42
+7
+20% +$117K ﹤0.01% 2775
2019
Q3 		$559K Buy
35
+4
+13% +$64.6K ﹤0.01% 2831
2019
Q2 		$659K Buy
31
+18
+138% +$445K ﹤0.01% 2882
2019
Q1 		$373K Buy
13
+8
+160% +$192K ﹤0.01% 3032
2018
Q4 		$81K Sell
5
-4
-44% -$89.5K ﹤0.01% 3254
2018
Q3 		$308K Buy
+9
New +$278K ﹤0.01% 3011

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jim Simons's YARW Position: Q1 2026 in Review

Jim Simons opened a new position in Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026: 346 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #3197 among its holdings. This is a return to the name: Jim Simons previously reported a position in YARW as recently as Q2 2025.

Jim Simons first reported a position in YARW in Q3 2018 and has held it in 26 quarters since. The position peaked at $1.73M in Q3 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Jim Simons held 346 shares of Yarrow Bioscience, Inc. Common Stock worth $10.3K as of Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock was a new Jim Simons position in Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3197 holding.
  • Jim Simons first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and has held it in 26 quarters since.
  • Jim Simons's Yarrow Bioscience, Inc. Common Stock position peaked at $1.73M in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.